Eccrine carcinoma
(Redirected from Syringoid carcinoma)
A rare type of sweat gland cancer
| Classification |
|
|---|---|
| External resources |
|
Eccrine Carcinoma[edit | edit source]
Eccrine carcinoma is a rare form of skin cancer that originates from the eccrine sweat glands. These glands are responsible for the production of sweat and are distributed throughout the human body, with a higher concentration on the palms, soles, and forehead.
Pathophysiology[edit | edit source]
Eccrine carcinoma arises from the epithelial cells of the eccrine sweat glands. These tumors can exhibit a variety of histological patterns, making diagnosis challenging. The cancerous cells can invade surrounding tissues and, in some cases, metastasize to distant organs.
Clinical Presentation[edit | edit source]
Patients with eccrine carcinoma typically present with a slow-growing, painless nodule on the skin. The lesion may appear as a solitary, firm, and sometimes ulcerated mass. Common sites include the head, neck, and extremities, reflecting the distribution of eccrine glands.
Diagnosis[edit | edit source]
The diagnosis of eccrine carcinoma is primarily based on histopathological examination. A biopsy of the lesion is performed, and the tissue is analyzed under a microscope. Immunohistochemical staining may be used to differentiate eccrine carcinoma from other types of skin tumors.
Treatment[edit | edit source]
The primary treatment for eccrine carcinoma is surgical excision with clear margins. In cases where the tumor is not resectable or has metastasized, additional treatments such as radiation therapy or chemotherapy may be considered. The choice of treatment depends on the stage of the cancer and the overall health of the patient.
Prognosis[edit | edit source]
The prognosis for patients with eccrine carcinoma varies depending on the stage at diagnosis and the presence of metastasis. Early detection and complete surgical removal of the tumor generally result in a favorable outcome. However, advanced cases with distant metastasis have a poorer prognosis.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
